New day centre in Hong Kong to roll out clinical LLM, remote monitoring solutions
Gleneagles Hospital Hong Kong is collaborating with two startups to integrate AI-powered clinical solutions at its new day procedure centre.
According to the hospital, a camera-based vital signs monitoring technology by Panoptic AI and a multimodal large language model-driven (LLM) patient consultation platform by SmartCare will form an integrated smart solution that will digitise workflows at Gleneagles MediCentre, which is set to launch later this year. The smart solution will initially provide virtual client servicing, online pre-checkin, and patient triage, among other features.
There is also potential to expand the implementation of the integrated solution across Gleneagles' network of seven clinics and other services, a press release noted.
New COE for AI in healthcare in India to be set up
The Indian Institute of Technology Delhi (IIT Delhi) and the All India Institute of Medical Science Delhi (AIIMS Delhi) have agreed to establish a centre of excellence for AI in healthcare.
The two public universities signed a memorandum of understanding to set up the COE, which will develop AI-powered solutions to support India's national health programs.
"Our aim is to develop cutting-edge AI solutions to upscale health services, upskill our healthcare providers, and improve the accessibility of quality healthcare to remote and marginalised sections of our population," explained IIT Delhi computer science and engineering professor Chetan Arora in a statement.
Last year, the two institutes were awarded a national government grant worth 330 crore rupees ($38 million) to develop these solutions.
"A partnership between AIIMS [Delhi] and IIT Delhi has the potential to transform [AI] for affordable healthcare," IIT Delhi director and professor Rangan Banerjee commented.
KPJ Healthcare launches AI patient chatbot
Private healthcare provider KPJ Healthcare in Malaysia has worked with IBM Malaysia to deploy an AI-powered chatbot.
The chatbot, built on the cloud-based generative AI platform IBM watsonx, aims to improve patient experience by assisting in managing routine patient information requests.
Integrating deep learning, machine learning, and natural language processing, the chatbot is accessible 24/7 to provide answers to frequently asked questions, specialist details, and appointment scheduling.
"With this AI-powered chatbot, we are able to deliver timely and accurate information to support our broader goal of building a smarter, more connected healthcare system," said KPJ Healthcare president and managing director Chin Keat Chyuan.
HKUST testing breast cancer genAI with over 10 hospitals
The Hong Kong University of Science and Technology (HKUST) is reportedly working with more than ten hospitals and partner institutions to test and validate its generative AI model for breast cancer detection.
The Mixture of Modality Experts (MOME), trained on a large dataset on breast cancer in China, has been shown in a study to accurately classify tumour malignancy on par with experienced radiologists. It has also correctly identified benign cases among BI-RADS 4 patients, predicted responses to neoadjuvant chemotherapy, and subtyped triple-negative breast cancer.
Among partner institutions involved in ongoing clinical feasibility and validation studies are Shenzhen People’s Hospital, the Guangzhou First Municipal People's Hospital, and Yunnan Cancer Center.
MOME is one of the four latest healthcare LLMs developed through HKUST's AI supercomputing facility.
Online Ayush portal for reporting misleading ads, ADRs launched
The government of India has set up an online portal for reporting misleading advertisements and adverse drug reactions related to traditional medicines collectively called Ayush (ayurveda, yoga, naturopathy, unani, siddha, and homoeopathy).
The AyushSuraksha portal, according to Health and Family Welfare and Ayush Minister Prataprao Jadhav, "will serve as vigilant watchtower against misleading advertisements and ensure that only safe and credible products reach the people."
It allows consumers, healthcare professionals, and regulatory authorities to directly report misleading ads or ADRs. The authorities can also track these reports in real-time, enabling quick regulatory action and systematic data analysis.
The launch of the online portal was in response to a Supreme Court order last year to establish a system allowing state licensing authorities to report complaints, share interstate referrals, and update the status of actions taken regarding misleading ads and ADRs related to Ayush. The Supreme Court set a deadline for launching this system this month, June.
AyushSuraksha was developed with the support of the Central Council for Research in Siddha and is aligned with the National Pharmacovigilance Program.
